Prescribing prevalence and trends of medications with pharmacogenetic implications: a study based on primary care data in Manitoba, Canada
Open Access
- 30 October 2026
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- p. 1-9
Abstract
No abstract availableFunding Information
- University of Manitoba (University Research Grants Program (URGP))
This publication has 36 references indexed in Scilit:
- Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV StudyGenetics in Medicine Open, 2026
- Advancing Clinical Pharmacogenomics Worldwide Through the Clinical Pharmacogenetics Implementation Consortium ( CPIC )Clinical Pharmacology & Therapeutics, 2025
- Insights Into Patient‐Level Exposure to Actionable Pharmacogenomic Medications in Australia Using a New National Pharmacogenomic GuidelineClinical Pharmacology & Therapeutics, 2025
- Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesClinical Pharmacology & Therapeutics, 2025
- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker TherapyClinical Pharmacology & Therapeutics, 2024
- How to implement a pharmacogenetics service at your institutionJACCP: Journal of the American College of Clinical Pharmacy, 2022
- Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric PatientsJAMA Network Open, 2020
- An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genesJournal of Neural Transmission, 2018
- Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE networkClinical Pharmacology & Therapeutics, 2016
- Parsing interindividual drug variability: an emerging role for systems pharmacologyWIREs Mechanisms of Disease, 2015